Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Dermatol ; 24(4): 309-12, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25690483

ABSTRACT

CXCL5 has recently been identified as a mediator of UVB-induced pain in rodents. To compare and to extend previous knowledge of cutaneous CXCL5 regulation, we performed a comprehensive study on the effects of UV radiation on CXCL5 regulation in human skin. Our results show a dose-dependent increase in CXCL5 protein in human skin after UV radiation. CXCL5 can be released by different cell types in the skin. We presumed that, in addition to immune cells, non-immune skin cells also contribute to UV-induced increase in CXCL5 protein. Analysis of monocultured dermal fibroblasts and keratinocytes revealed that only fibroblasts but not keratinocytes displayed up regulated CXCL5 levels after UV stimulation. Whereas UV treatment of human skin equivalents, induced epidermal CXCL5 mRNA and protein expression. Up regulation of epidermal CXCL5 was independent of keratinocyte differentiation and keratinocyte-keratinocyte interactions in epidermal layers. Our findings provide first evidence on the release of CXCL5 in UV-radiated human skin and the essential role of fibroblast-keratinocyte interaction in the regulation of epidermal CXCL5.


Subject(s)
Chemokine CXCL5/genetics , Chemokine CXCL5/metabolism , Skin/immunology , Skin/radiation effects , Ultraviolet Rays/adverse effects , Cells, Cultured , Coculture Techniques , Female , Fibroblasts/immunology , Fibroblasts/metabolism , Fibroblasts/radiation effects , Humans , Keratinocytes/immunology , Keratinocytes/metabolism , Keratinocytes/radiation effects , Middle Aged , RNA, Messenger/genetics , RNA, Messenger/metabolism , Skin/metabolism , Up-Regulation/radiation effects
3.
Mol Cell Biochem ; 306(1-2): 153-62, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17660950

ABSTRACT

The creatine kinase (CK) system is essential for cellular energetics in tissues or cells with high and fluctuating energy requirements. Creatine itself is known to protect cells from stress-induced injury. By using an siRNA approach to silence the CK isoenzymes in human keratinocyte HaCaT cells, expressing low levels of cytoplasmic CK and high levels of mitochondrial CK, as well as HeLa cancer cells, expressing high levels of cytoplasmic CK and low levels of mitochondrial CK, we successfully lowered the respective CK expression levels and studied the effects of either abolishing cytosolic brain-type BB-CK or ubiquitous mitochondrial uMi-CK in these cells. In both cell lines, targeting the dominant CK isoform by the respective siRNAs had the strongest effect on overall CK activity. However, irrespective of the expression level in both cell lines, inhibition of the mitochondrial CK isoform generally caused the strongest decline in cell viability and cell proliferation. These findings are congruent with electron microscopic data showing substantial alteration of mitochondrial morphology as well as mitochondrial membrane topology after targeting uMi-CK in both cell lines. Only for the rate of apoptosis, it was the least expressed CK present in each of the cell lines whose inhibition led to the highest proportion of apoptotic cells, i.e., downregulation of uMi-CK in case of HeLaS3 and BB-CK in case of HaCaT cells. We conclude from these data that a major phenotype is linked to reduction of mitochondrial CK alone or in combination with cytosolic CK, and that this effect is independent of the relative expression levels of Mi-CK in the cell type considered. The mitochondrial CK isoform appears to play the most crucial role in maintaining cell viability by stabilizing contact sites between inner and outer mitochondrial membranes and maintaining local metabolite channeling, thus avoiding transition pore opening which eventually results in activation of caspase cell-death pathways.


Subject(s)
Cell Survival/physiology , Creatine Kinase, BB Form/antagonists & inhibitors , Creatine Kinase, Mitochondrial Form/antagonists & inhibitors , Keratinocytes/metabolism , Mitochondria/enzymology , RNA, Small Interfering/pharmacology , Creatine Kinase, BB Form/biosynthesis , Creatine Kinase, BB Form/genetics , Creatine Kinase, Mitochondrial Form/biosynthesis , Creatine Kinase, Mitochondrial Form/genetics , Cytosol/enzymology , Gene Expression Regulation/drug effects , HeLa Cells/drug effects , HeLa Cells/enzymology , Humans , Isoenzymes , Mitochondria/drug effects , Phosphocreatine/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...